Ontario Bioscience Industry Organization
VC Fund
Toronto, Canada
Ontario Bioscience Industry Organization is a VC fund in Toronto focused on Biotechnology and Biopharma. The Ontario Bioscience Industry Organization (OBIO) is a private sector.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Ontario Bioscience Industry Organization invests in
Stages Ontario Bioscience Industry Organization invests in
Countries Ontario Bioscience Industry Organization invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Investment Focus
Industry
- Biotechnology 3 (60%)
- Biopharma 2 (40%)
- Medical Device 2 (40%)
- Health Care 1 (20%)
- Life Science 1 (20%)
Stage
- Seed 3 (60%)
- Grant 1 (20%)
- Pre-Seed 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Colin Foster
Ontario Bioscience Innovation Organization - CAAP Committee Member
|
Ontario Bioscience Innovation Organization - CAAP Committee Member | Total investments: 0 | Find email | |
Paul Santaguida
Consultant
|
Consultant | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Block Biosciences
|
Block Biosciences is a life‑sciences startup that develops small‑molecule therapeutics aimed at blocking the spread of cancer to the brain. The company works on inhibiting specific metabolic pathways that cancer cells use to initiate brain metastases, using predictive models and targeted drug design. It also explores companion‑diagnostic‑type toolsto help identify patients at high risk for brain spread. | $73.1K / Pre-Seed / Mar 05, 2026 | |
HDAX Therapeutics
|
HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes. | $3.2M / Seed / Sep 05, 2024 | |
Tenomix
|
Tenomix mission is to develop novel technologies that target inefficiencies in the pathology workflow optimize cancer care and reduce healthcare costs | $1.6M / Seed / Mar 01, 2024 | |
Qidni Labs
|
Over two million patients around the world suffer from End Stage Renal Disease (ESRD). Patients' survival depends on dialysis, a renal replacement therapy that they undergo until they receive a kidney transplant. The survival rate of patients under dialysis is less than 40% in 5 years (1).A year of dialysis of each patient may cost upwardsof $60,000 in Canada and the United States. Patients endure a lot more hardships due to complications and lifestyle restrictions. Studies show that longer treatment times can potentially be associated with prolonged survival. | Grant / Jul 27, 2021 | |
AmacaThera
|
AmacaThera is a clinical-stage company based in Toronto. AmacaThera is redefining how therapeutics are delivered. AmacaThera has developed a platform hydrogel technology that addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. AmacaThera’s lead product addresses post-operative painand consequently may have an impact on the opioid crisis. | Seed / Jan 01, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Ontario Bioscience Industry Organization invest in?
Ontario Bioscience Industry Organization invests primarily in Biotechnology, Biopharma and Medical Device startups, most often at Seed and Grant stage. Most of the 5 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ontario Bioscience Industry Organization?
Public channels for Ontario Bioscience Industry Organization include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Ontario Bioscience Industry Organization?
The team at Ontario Bioscience Industry Organization includes Colin Foster (Ontario Bioscience Innovation Organization - CAAP Committee Member) and Paul Santaguida (Consultant). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
